Leawood Woman Charged With Importing Misbranded Drugs

Leawood Woman Charged With Importing Misbranded Drugs

The following press release was published by the U.S. Department of Justice, Office of the United States Attorneys on June 16, 2017. It is reproduced in full below.

KANSAS CITY, KAN. - A Leawood woman was charged Friday with importing $194,000 worth of misbranded drugs, U.S. Attorney Tom Beall said.

Kathleen Stegman, 59, who owned Midwest Medical Aesthetics Center, Inc., of Leawood, Kan., was charged with obtaining Botox, Dysport, Restylane, Perlane and Sculptra from foreign sources. The drugs did not meet Food and Drug Administration labeling requirements. The crime is alleged to have occurred in 2011, 2012 and 2013.

In October 2016, Stegman was sentenced to 51 months in federal prison for tax evasion.

If convicted, she faces up to three years in federal prison, a fine up to $250,000 and forfeiture. The Food and Drug Administration’s Office of Criminal Investigation investigated. Assistant U.S. Attorney Tanya Treadway is prosecuting.

Source: U.S. Department of Justice, Office of the United States Attorneys

More News